Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy

Redman, 2005, Latest advances in understanding preeclampsia, Science, 308, 1592, 10.1126/science.1111726 Gerretsen, 1981, Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation, BJOG, 88, 876, 10.1111/j.1471-0528.1981.tb02222.x Brosens, 1972, The role of the spiral arteries in the pathogenesis of preeclampsia, Obstet Gynecol Annu, 1, 177 Lain, 2002, Contemporary concepts of the pathogenesis and management of preeclampsia, JAMA, 287, 3183, 10.1001/jama.287.24.3183 Burton, 2009, Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy, Placenta, 30, 473, 10.1016/j.placenta.2009.02.009 Kanter, 2010, Angiogenic dysfunction in molar pregnancy, Am J Obstet Gynecol, 202, 184.e1, 10.1016/j.ajog.2009.09.005 Roberts, 2001, Pathogenesis and genetics of pre-eclampsia, Lancet, 357, 53, 10.1016/S0140-6736(00)03577-7 Brosens, 1967, The physiological response of the vessels of the placental bed to normal pregnancy, J Pathol Bacteriol, 93, 569, 10.1002/path.1700930218 Taylor, 1998, Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia, Semin Reprod Endocrinol, 16, 17, 10.1055/s-2007-1016249 Taylor, 2003, Longitudinal serum concentrations of placental growth factor: Evidence for abnormal placental angiogenesis in pathologic pregnancies, An J Obstet Gynecol, 188, 177, 10.1067/mob.2003.111 Maynard, 2003, Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia, J Clin Invest, 111, 649, 10.1172/JCI17189 Levine, 2006, Soluble endoglin and other circulating antiangiogenic factors in preeclampsia, N Engl J Med, 355, 992, 10.1056/NEJMoa055352 Levine, 2004, Circulating angiogenic factors and the risk of preeclampsia, N Engl J Med, 350, 672, 10.1056/NEJMoa031884 Vaisbuch, 2011, Circulating angiogenic and antiangiogenic factors in women with eclampsia, Am J Obstet Gynecol, 204, 152.e1, 10.1016/j.ajog.2010.08.049 Zhou, 1997, Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype: one cause of defective endovascular invasion in this syndrome?, J Clin Invest, 99, 2152, 10.1172/JCI119388 Zeek, 1950, Vascular changes in the decidua associated with eclamptogenic toxemia of pregnancy, Am J Clin Pathol, 20, 1099, 10.1093/ajcp/20.12.1099 Browne, 1953, The maternal placental blood flow in normotensive and hypertensive women, J Obstet Gynaecol Br Emp, 60, 141, 10.1111/j.1471-0528.1953.tb07668.x Chaiworapongsa, 2005, Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia, J Matern Fetal Neonatal Med, 17, 3, 10.1080/14767050400028816 Lim, 2008, Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors, Obstet Gynecol, 111, 1403, 10.1097/AOG.0b013e3181719b7a De Vivo, 2008, Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia, Acta Obstet Gynecol Scand, 87, 837, 10.1080/00016340802253759 Hertig, 2004, Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia, Clin Chem, 50, 1702, 10.1373/clinchem.2004.036715 Park, 2005, An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia, Am J Obstet Gynecol, 193, 984, 10.1016/j.ajog.2005.06.033 Romero, 2007, Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury, Nutr Rev, 65, S194, 10.1301/nr.2007.dec.S194-S202 Baumann, 2008, First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia, Am J Obstet Gynecol, 199, 266.e1, 10.1016/j.ajog.2008.06.069 Akolekar, 2008, Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia, Ultrasound Obstet Gynecol, 32, 732, 10.1002/uog.6244 Sunderji, 2010, Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study, Am J Obstet Gynecol, 202, 40.e1, 10.1016/j.ajog.2009.07.025 Verlohren, 2010, An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia, Am J Obstet Gynecol, 202, 161.e1, 10.1016/j.ajog.2009.09.016 Polliotti, 2003, Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia, Obstet Gynecol, 101, 1266 Shibata, 2005, Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor, J Clin Endocrinol Metab, 90, 4895, 10.1210/jc.2004-1955 Thadhani, 2004, First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia, J Clin Endocrinol Metab, 89, 770, 10.1210/jc.2003-031244 Erez, 2008, The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age, J Matern Fetal Neonatal Med, 21, 279, 10.1080/14767050802034545 Vatten, 2007, Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia, Am J Obstet Gynecol, 196, 239.e1, 10.1016/j.ajog.2006.10.909 Ong, 2001, First-trimester maternal serum levels of placenta growth factor as predictor of preeclampsia and fetal growth restriction, Obstet Gynecol, 98, 608 Eremina, 2003, Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases, J Clin Invest, 111, 707, 10.1172/JCI17423 Roberts, 2009, Pregnancy-related hypertension, 651 Troisi, 2008, Blood pressure augmentation and maternal circulating concentrations of angiogenic factors at delivery in preeclamptic and uncomplicated pregnancies, Am J Obstet Gynecol, 199, 653.e1, 10.1016/j.ajog.2008.06.030